Acadia Pharmaceuticals Inc. is dedicated to improving the lives of patients with neuro-psychiatric and rare diseases. The company has developed FDA-approved drugs for Parkinson’s disease psychosis and Rett syndrome, and is currently focused on treating Prader-Willi syndrome, Alzheimer’s disease psychosis, and other neurological conditions through clinical-stage development efforts.
Acadia Pharmaceuticals is seeking a Director of Clinical Trial Materials to support clinical development programs. This role involves planning, execution, budget management, and compliance to regulatory requirements. The Director will collaborate with internal and external teams to ensure timely and uninterrupted supply of clinical trial materials while providing comprehensive training to junior colleagues.
Acadia Pharmaceuticals Inc. is dedicated to improving the lives of patients with neuro-psychiatric and rare diseases. The company has developed FDA-approved drugs for Parkinson’s disease psychosis and Rett syndrome, and is currently focused on treating Prader-Willi syndrome, Alzheimer’s disease psychosis, and other neurological conditions through clinical-stage development efforts.
Apogee Therapeutics